These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 29533507)

  • 21. Targeted antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy during active surveillance: Effect on hospitalization.
    Cheung C; Patel HD; Landis P; Carter HB; Han M
    Urol Oncol; 2018 Apr; 36(4):158.e7-158.e12. PubMed ID: 29288004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of fluoroquinolone-resistant Escherichia coli before and incidence of acute bacterial prostatitis after prostate biopsy.
    Minamida S; Satoh T; Tabata K; Kimura M; Tsumura H; Kurosaka S; Matsumoto K; Fujita T; Iwamura M; Baba S
    Urology; 2011 Dec; 78(6):1235-9. PubMed ID: 21908030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rectal E. coli above ciprofloxacin ECOFF associate with infectious complications following prostate biopsy.
    Kalalahti I; Huotari K; Lahdensuo K; Tarkka E; Santti H; Rannikko A; Pätäri-Sampo A
    Eur J Clin Microbiol Infect Dis; 2018 Jun; 37(6):1055-1060. PubMed ID: 29500572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An antimicrobial prophylaxis protocol using rectal swab cultures for transrectal prostate biopsy.
    Summers SJ; Patel DP; Hamilton BD; Presson AP; Fisher MA; Lowrance WT; Southwick AW
    World J Urol; 2015 Dec; 33(12):2001-7. PubMed ID: 25935330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rectal Culture-Guided Targeted Antimicrobial Prophylaxis Reduces the Incidence of Post-Operative Infectious Complications in Men at High Risk for Infections Submitted to Transrectal Ultrasound Prostate Biopsy - Results of a Cross-Sectional Study.
    Boeri L; Fontana M; Gallioli A; Zanetti SP; Catellani M; Longo F; Mangiarotti B; Montanari E
    PLoS One; 2017; 12(1):e0170319. PubMed ID: 28122053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of antibiotic resistance in fecal flora of patients undergoing transrectal ultrasound-guided prostate biopsy in Thailand.
    Siriboon S; Tiengrim S; Taweemongkongsup T; Thamlikitkul V; Chayakulkeeree M
    Urol Int; 2012; 88(2):187-93. PubMed ID: 22269856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence and risk factors of resistant E. coli infections after prostate biopsy under fluoroquinolone prophylaxis: a single-centre experience with 2215 patients.
    Kandemir Ö; Bozlu M; Efesoy O; Güntekin O; Tek M; Akbay E
    J Chemother; 2016 Aug; 28(4):284-8. PubMed ID: 25630553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of targeted prophylactic antimicrobial therapy before transrectal ultrasonography-guided prostate biopsy in reducing infection rates: a systematic review.
    Cussans A; Somani BK; Basarab A; Dudderidge TJ
    BJU Int; 2016 May; 117(5):725-31. PubMed ID: 26709240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implications of faecal ESBL carriers undergoing TRUS-guided prostate biopsy (TRUSPB): role of screening prior to TRUSPB.
    Bhatt NR; Murphy CA; Wall N; McEvoy E; Flynn RJ; Thomas AZ; Manecksha RP; Murphy PG; Smyth LG
    Ir J Med Sci; 2020 Aug; 189(3):817-823. PubMed ID: 31873877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of ST131 among fluoroquinolone-resistant Escherichia coli obtained from rectal swabs before transrectal prostate biopsy.
    Liss MA; Peterson EM; Johnston B; Osann K; Johnson JR
    Urology; 2013 Mar; 81(3):548-55. PubMed ID: 23333000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
    Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
    Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
    Korkmaz N; Gurbuz Y; Sandikci F; Kul G; Tutuncu EE; Sencan I
    Urol J; 2020 Mar; 17(2):192-197. PubMed ID: 31364100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy.
    Liss MA; Chang A; Santos R; Nakama-Peeples A; Peterson EM; Osann K; Billimek J; Szabo RJ; Dash A
    J Urol; 2011 Apr; 185(4):1283-8. PubMed ID: 21334021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.
    Tchesnokova VL; Ottley LL; Sakamoto K; Fierer J; Sokurenko E; Liss MA
    Urology; 2015 Dec; 86(6):1200-5. PubMed ID: 26299464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escherichia coli bloodstream infection after transrectal ultrasound-guided prostate biopsy: implications of fluoroquinolone-resistant sequence type 131 as a major causative pathogen.
    Williamson DA; Roberts SA; Paterson DL; Sidjabat H; Silvey A; Masters J; Rice M; Freeman JT
    Clin Infect Dis; 2012 May; 54(10):1406-12. PubMed ID: 22419681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic resistance in adult female patients hospitalized for acute pyelonephritis: rates and predicting factors.
    Etienne M; Van Elslande H; Choplin-Renard J; Pestel-Caron M; Caron F
    Med Mal Infect; 2014 May; 44(5):217-22. PubMed ID: 24787633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
    Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
    Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of ciprofloxacin-resistant Enterobacteriaceae in the intestinal flora of patients undergoing transrectal prostate biopsy in Norwich, UK.
    Hanna MY; Tremlett C; Josan G; Eltom A; Mills R; Rochester M; Livermore DM
    BJU Int; 2015 Jul; 116(1):131-4. PubMed ID: 25079680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.